Bayview Pharmacy is pleased to present a specially compounded topical/vaginal formulation of Naltrexone HCl 0.5%, Ketotifen 0.05%, and Tacrolimus 0.03%. This unique combination of medications is designed to address a range of conditions, including vulvodynia, lichen sclerosus, and lichen planus.

Naltrexone HCl is an opioid antagonist that plays a crucial role in reducing pain and inflammation. Ketotifen, an antihistamine, aids in alleviating itching and inflammation. Tacrolimus, an immunosuppressant, contributes to the reduction of inflammation and scarring. The synergistic effect of these medications helps to alleviate the symptoms associated with these conditions.

This semisolid formulation is dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients in a gel-like consistency. This method of delivery ensures that the medication is applied exactly where it's needed, enhancing its effectiveness while minimizing potential side effects.

As an effective treatment option, this formulation is safe and generally well-tolerated, making it suitable for long-term use. However, patients should be aware that they may experience some side effects, such as burning, itching, or irritation. It's important to report any adverse reactions to your healthcare provider promptly.

Healthcare providers should note that this is a compounded medication, requiring careful use and close monitoring of patients for any adverse reactions or side effects. As with all medications, it's crucial to use this formulation as directed by a healthcare professional.

If you have any questions about this unique formulation or how it can be used to treat vulvodynia, lichen sclerosus, or lichen planus, please don't hesitate to contact us at Bayview Pharmacy. We're here to provide the support and information you need.

This compounded formulation of Naltrexone HCl 0.5%/Ketotifen 0.05%/Tacrolimus 0.03% Topical/Vaginal is a semisolid preparation that is dispensed through a pump mechanism. This design allows for easy and precise application on the skin or vaginal area, ensuring targeted treatment or absorption of the active ingredients in a gel-like consistency.

The formulation is indicated for the treatment of various disease states. It has demonstrated efficacy in the treatment of atopic dermatitis, psoriasis, and other inflammatory skin conditions. Additionally, it has been used to treat vulvovaginal candidiasis, bacterial vaginosis, and other vaginal infections. It has also been employed in the management of vulvodynia, a chronic pain condition of the vulva.

The combination of Naltrexone HCl and Ketotifen works to reduce inflammation and itching associated with atopic dermatitis and other inflammatory skin conditions. Naltrexone HCl is an opioid antagonist that functions by blocking the effects of opioids on the body. Ketotifen is an antihistamine that operates by blocking the action of histamine, a chemical released by the body during an allergic reaction.

Tacrolimus is an immunosuppressant that functions by suppressing the immune system. It has been used to treat atopic dermatitis, psoriasis, and other inflammatory skin conditions. It has also been used to treat vulvovaginal candidiasis, bacterial vaginosis, and other vaginal infections.

The combination of Naltrexone HCl, Ketotifen, and Tacrolimus has demonstrated effectiveness in the treatment of various disease states. However, it is crucial to note that this formulation should be used with caution in patients with a history of allergies or other medical conditions. It is also important to monitor for any potential side effects, such as skin irritation, itching, or burning.

If you have any questions about this formulation or its use in the treatment of various disease states, please do not hesitate to reach out for further information.

Naltrexone HCl 0.5%/Ketotifen 0.05%/Tacrolimus 0.03% Topical/Vaginal is a compounded formulation that combines three potent medications, each with a unique mechanism of action, to effectively treat a range of skin conditions. This formulation is dispensed as a semisolid gel through a pump mechanism, ensuring easy and precise application.

Naltrexone HCl, an opioid antagonist, works by reducing inflammation and itching, providing relief from discomfort. Ketotifen, an antihistamine, further aids in reducing itching and inflammation, enhancing the overall effectiveness of the treatment. Tacrolimus, an immunosuppressant, contributes to the reduction of inflammation and redness, providing a comprehensive solution for skin conditions such as eczema, psoriasis, and contact dermatitis.

When applied topically or vaginally, this formulation works synergistically to alleviate symptoms by reducing inflammation, itching, and redness. It also suppresses the immune system to further reduce redness and prevent flare-ups. It is crucial to follow your healthcare provider's instructions when using this medication to ensure optimal results and minimize potential side effects.

While applying the medication, care should be taken to avoid contact with the eyes. If you experience any discomfort or have any questions about using this formulation, it is recommended to consult with your healthcare provider or pharmacist. They can provide guidance and address any concerns you may have regarding the treatment.

This compounded formulation of Naltrexone HCl 0.5%/Ketotifen 0.05%/Tacrolimus 0.03% Topical/Vaginal is a versatile treatment option for a variety of skin and vaginal conditions. It is indicated for the treatment of inflammatory skin conditions such as contact dermatitis, seborrheic dermatitis, pruritus, acne, rosacea, and eczema. Additionally, it can be used to treat inflammatory conditions of the vulva and vagina, including lichen simplex chronicus, lichen sclerosus, and lichen planus.

Furthermore, this formulation can be used to treat other conditions of the vulva and vagina, such as bacterial vaginosis, vulvovaginal atrophy, vulvovaginal candidiasis, vulvodynia, vulvar vestibulitis, and vulvar intraepithelial neoplasia. It can also be used to address vulvar cancer, vulvar intraepithelial neoplasia, and vulvar lichen sclerosus.

Moreover, this formulation can be used to alleviate symptoms such as vulvar itching, vulvar burning, and vulvar pain. It can also be used to treat vulvar ulcers, vulvar swelling, and vulvar bleeding. Conditions such as vulvar dermatitis, vulvar psoriasis, and vulvar eczema can also be treated with this formulation.

If you have any questions about the use of this formulation for any of the conditions mentioned above, please do not hesitate to reach out for further information.